Scholarlink

<p>Mirtazapine is an atypical tetracyclic antidepressant drug that binds to several monoamine neurotransmitter receptors. For instance, mirtazapine binds to H<sub>1</sub>-histamine receptors in vitro and in the brain of patients in vivo. Here, we hypothesize that mirtazapine is an antagonist at human cardiac H<sub>1</sub>-histamine receptors. To test this hypothesis, we measured force of contraction in isolated electrically stimulated (1&#xa0;Hz) left atrial preparations (LA) and spontaneously beating right atrial preparations (RA) from adult transgenic mice with cardiomyocyte-specific overexpression of the human H<sub>1</sub>-histamine receptor (H<sub>1</sub>-TG). These findings were compared with those in wild-type littermate mice (WT). Finally, we measured the force of contraction in isolated electrically stimulated right atrial muscle strips (HAP) gotten from adult patients who were undergoing bypass surgery. Mirtazapine concentration- and time-dependently decreased H<sub>1</sub>-histamine receptor-stimulated force of contraction in LA and RA from H<sub>1</sub>-TG. Importantly, mirtazapine (starting at 100&#xa0;nM) concentration- and time-dependently decreased H<sub>1</sub>-histamine receptor-stimulated force of contraction in HAP. We thus conclude that mirtazapine can antagonize human cardiac H<sub>1</sub>-histamine receptors at therapeutic drug concentrations, and thus, mirtazapine may have cardiac untoward effects in psychiatric patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Mirtazapine is a functional antagonist at cardiac human H1-histamine receptors

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月20日

查看全文
  • Thanh Hoai Pham,
  • Jonas M. A. Schlicht,
  • Britt Hofmann,
  • Uwe Kirchhefer,
  • Joachim Neumann,
  • Ulrich Gergs

摘要

Mirtazapine is an atypical tetracyclic antidepressant drug that binds to several monoamine neurotransmitter receptors. For instance, mirtazapine binds to H1-histamine receptors in vitro and in the brain of patients in vivo. Here, we hypothesize that mirtazapine is an antagonist at human cardiac H1-histamine receptors. To test this hypothesis, we measured force of contraction in isolated electrically stimulated (1 Hz) left atrial preparations (LA) and spontaneously beating right atrial preparations (RA) from adult transgenic mice with cardiomyocyte-specific overexpression of the human H1-histamine receptor (H1-TG). These findings were compared with those in wild-type littermate mice (WT). Finally, we measured the force of contraction in isolated electrically stimulated right atrial muscle strips (HAP) gotten from adult patients who were undergoing bypass surgery. Mirtazapine concentration- and time-dependently decreased H1-histamine receptor-stimulated force of contraction in LA and RA from H1-TG. Importantly, mirtazapine (starting at 100 nM) concentration- and time-dependently decreased H1-histamine receptor-stimulated force of contraction in HAP. We thus conclude that mirtazapine can antagonize human cardiac H1-histamine receptors at therapeutic drug concentrations, and thus, mirtazapine may have cardiac untoward effects in psychiatric patients.